Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main protease
Bioorganic & Medicinal Chemistry Letters · 2026-10 · 139 · 130692
DOI: 10.1016/j.bmcl.2026.130692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-10. Verfasst von Lauren R Blankenship und 5 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Disulfides, Cysteine, Coronavirus 3C Proteases. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
SARS-CoV-2 main protease (MPro) is a cysteine enzyme essential for viral replication and pathogenesis. It contains multiple cysteines that are susceptible to covalent modifications. Reported modifications include inhibitor-derived modifications at the catalytic Cys145, Cys145-Cys117 disulfide, an S-O-N (SON) crosslink between Cys22 and Lys61, and S-O-N-O-S (SONOS) crosslink spanning Cys22-Lys61-Cys44, Cys300 S-glutathionylation, and inhibitor-derived adducts on Cys156 and Cys300. Reanalysis of MPro crystal structures obtained from samples exposed to air identified nine structures containing the SON crosslink and thirty-one containing the SONOS crosslink. Among five newly determined structures, one unexpectedly showed a Cys22-Cys44 disulfide. Cys44 lies in a segment that contributes to the active site architecture but is flexible to adopt alternative conformations. Redox transformations at this position by formation of either SONOS crosslink or disulfide suggest potential redox regulation of MPro activity in host cells experiencing virus-induced oxidative stress. A C22S mutant enzyme displays much higher activity than wild type enzyme supporting potential redox regulation mechanisms involving Cys22 and Cys44.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University, College Station, TX 77843, USA.
- Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Laurence Berkeley National Laboratory, Berkeley, CA 94720, United States.
- Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University, College Station, TX 77843, USA; Department of Pharmaceutical Sciences, Irma Lerma College of Pharmacy, Texas A&M University, College Sta…
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIBIB NIH HHS
- Office of Science
- National Institutes of Health
- National Institute of General Medical Sciences
- Cancer Prevention and Research Institute of Texas
- Texas A and M University
Zitieren
APA
Blankenship, L. R., Yang, K., Cho, C. D., Chen, Y. P., Sankaran, B., & Liu, W. R. (2026). Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main protease. Bioorganic & Medicinal Chemistry Letters, 139, 130692. https://doi.org/10.1016/j.bmcl.2026.130692
Vancouver
Blankenship LR, Yang K, Cho CD, Chen YP, Sankaran B, Liu WR. Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main protease. Bioorganic & Medicinal Chemistry Letters. 2026;139:130692. doi:10.1016/j.bmcl.2026.130692
BibTeX
@article{Blankenship2026,
author = {Blankenship, Lauren R and Yang, Kai and Cho, Chia-Chuan Dean and Chen, Yi-Ju Penny and Sankaran, Banumathi and Liu, Wenshe Ray},
title = {Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main protease},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2026},
volume = {139},
pages = {130692},
doi = {10.1016/j.bmcl.2026.130692}
}
EUVIMED